The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: Structure-function relationships

Annals of Oncology

Volumn 18, Issue SUPPL. 6, 2007, Pages

  Sisci, D ^a   Morelli, C ^a   Cascio, S ^b   Lanzino, M ^a   Garofalo, C ^a   Reiss, K ^c   Garcia, M ^d   Russo, A ^b   Ando S ^a   Surmacz, E ^e  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSERM   (France)

^e TEMPLE UNIVERSITY   (United States)

Author keywords

Breast cancer; Estrogen receptor alpha (ERa); Insulin receptor substrate 1 (IRS 1)

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; INSULIN RECEPTOR SUBSTRATE 1; SOMATOMEDIN C; IFNGR2 PROTEIN, HUMAN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; INTERFERON RECEPTOR; PEPTIDE FRAGMENT; PHOSPHOPROTEIN; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BREAST CANCER; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CONFERENCE PAPER; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MUTANT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; ACTIVE TRANSPORT; ARTICLE; BREAST TUMOR; DRUG ANTAGONISM; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, INSULIN; RECEPTORS, INTERFERON; REPRESSOR PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 35748930595     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm232     Document Type: Conference Paper

References (33)

1. Sisci D, Surmacz E. Crosstalk between IGF signaling and steroid hormone receptors in breast cancer. Curr Pharm Des 2007; 13: 705-717.
2. Surmacz E. Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia 2000; 5: 95-105.
3. Lange CA. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: Who will have the last word? Mol Endocrinol 2004; 18: 269-278.
4. Weigel NL, Zhang Y. Ligand-independent activation of steroid hormone receptors. J Mol Med 1998; 76: 469-479.
5. Lannigan DA. Estrogen receptor phosphorylation. Steroids 2003; 68: 1-9.
6. Edwards DP, Weigel NL, Nordeen SK, Beck CA. Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res Treat 1993; 27: 41-56.
7. Shupnik MA. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: Implications for cell proliferation. Oncogene 2004; 23: 7979-7989.
8. Umayahara Y, Kawamori R, Watada H et al. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 1994; 269: 16433-16442.
9. Stewart AJ, Johnson MD, May FE, Westley BR. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990; 265: 21172-21178.
10. Qin C, Singh P, Safe S. Transcriptional activation of insulin-like growth factor-binding protein-4 by 17beta-estradiol in MCF-7 cells: Role of estrogen receptor-Sp1 complexes. Endocrinology 1999; 140: 2501-2508.
11. Salerno M, Sisci D, Mauro L et al. Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells. Int J Cancer 1999; 81: 299-304.
12. Molloy CA, May FE, Westley BR. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J Biol Chem 2000; 275: 12565-12571.
13. Lee AV, Jackson JG, Gooch JL et al. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 1999; 13: 787-796.
14. White MF. The insulin signalling system and the IRS proteins. Diabetologia 1997; 40 (Suppl 2): S2-S17.
15. Lassak A, Del Valle L, Peruzzi F et al. Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem 2002; 277: 17231-17238.
16. Ma ZQ, Santagati S, Patrone C et al. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol 1994; 8: 910-918.
17. Sisci D, Morelli C, Garofalo C et al. Expression of nuclear insulin receptor substrate 1 (IRS-1) in breast cancer. J Clin Pathol 2006; [Epub ahead of print].
18. Morelli C, Garofalo C, Sisci D et al. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. Oncogene 2004; 23: 7517-7526.
19. Myers MG Jr., Sun XJ, White MF. The IRS-1 signaling system. Trends Biochem Sci 1994; 19: 289-293.
20. Kumar V, Green S, Stack G et al. Functional domains of the human estrogen receptor. Cell 1987; 51: 941-951.
21. Platet N, Cunat S, Chalbos D et al. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol Endocrinol 2000; 14: 999-1009.
22. Sisci D, Aquila S, Middea E et al. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: Effect on breast cancer cell motility. Oncogene 2004; 23: 8920-8930.
23. Cesarone G, Garofalo C, Abrams MT et al. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. J Cell Biochem 2006; 98: 440-450.
24. Surmacz E, Bartucci M. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer. J Exp Clin Cancer Res 2004; 23: 385-394.
25. Sachdev D, Yee D. The IGF system and breast cancer. Endocr Relat Cancer 2001; 8: 197-209.
26. Prisco M, Santini F, Baffa R et al. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J Biol Chem 2002; 277: 32078-32085.
27. Sun H, Tu X, Prisco M et al. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol Endocrinol 2003; 17: 472-486.
28. Martin MB, Franke TF, Stoica GE et al. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 2000; 141: 4503-4511.
29. Cascio S, Bartella V, Garofalo C et al. Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. J Biol Chem 2007; 282: 3498-3506.
30. Wegele H, Muller L, Buchner J. Hsp70 and Hsp90-a relay team for protein folding. Rev Physiol Biochem Pharmacol 2004; 151: 1-44.
31. Kato S, Endoh H, Masuhiro Y et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270: 1491-1494.
32. Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996; 15: 2174-2183.
33. Lee AV, Weng CN, Jackson JG, Yee D. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol 1997; 152: 39-47.